LIP
SNDX icon

Lighthouse Investment Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Lighthouse Investment Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-55,297
Closed -$1.32M – 526
2024
Q1 		$1.32M Buy
55,297
+3,098
+6% +$69.1K 0.06% 268
2023
Q4 		$1.13M Buy
+52,199
New +$802K 0.05% 221

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Lighthouse Investment Partners's SNDX Position: Q2 2024 in Review

Lighthouse Investment Partners sold out of Syndax Pharmaceuticals (SNDX) in Q2 2024, closing a stake of 55,297 shares — an estimated $1.32M sold.

Lighthouse Investment Partners first reported a position in SNDX in Q4 2023 and held it in 2 quarters. The position peaked at $1.32M in Q1 2024. 196 funds tracked by Wall St. Rank hold SNDX as of Q2 2024.

  • Lighthouse Investment Partners reported no remaining Syndax Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Lighthouse Investment Partners sold 55,297 Syndax Pharmaceuticals shares in Q2 2024, an estimated $1.32M.
  • Lighthouse Investment Partners first reported a position in Syndax Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • Lighthouse Investment Partners's Syndax Pharmaceuticals position peaked at $1.32M in Q1 2024.
  • 196 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2024.

Based on Lighthouse Investment Partners's 13F filing for Q2 2024, filed 14 Aug 2024.